네오켄바이오

1 known investors

NeoCannBio is a technology spin-off from KIST developing cannabinoid-based pharmaceuticals and producing hemp-derived cannabinoid drug ingredients, including high-purity CBD via microwave processing and GMP production. The company builds a broad cannabinoid library and develops new drugs for patients with rare and intractable diseases in Korea.

BiotechDeep TechHealthtech